# Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers

> **NCT05561621** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 70 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** Voice analysis

## Key facts

- **NCT ID:** NCT05561621
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-15
- **Primary completion:** 2022-12-20
- **Final completion:** 2022-12-20
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05561621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05561621, "Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05561621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*